mircera
roche registration gmbh - metoksy polyetylen glykol-epoetin beta - anemia; kidney failure, chronic - antianemiske preparater - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.
velphoro
vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - legemidler for behandling av hyperkalemi og hyperphosphatemia - velphoro er indisert for kontroll av serumfosfornivåer hos pasienter med kronisk nyresykdom (ckd) hos hemodialyse (hd) eller peritonealdialyse (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.
ventoline 0.5 mg/ ml
glaxosmithkline as - salbutamolsulfat - inhalasjonsvæske til nebulisator, oppløsning - 0.5 mg/ ml
ventoline 1 mg/ ml
glaxosmithkline as - salbutamolsulfat - inhalasjonsvæske til nebulisator, oppløsning - 1 mg/ ml
ventoline 2 mg/ ml
glaxosmithkline as - salbutamolsulfat - inhalasjonsvæske til nebulisator, oppløsning - 2 mg/ ml
zofran 16 mg
novartis norge as - ondansetronhydroklorid - stikkpille - 16 mg